Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant Metastases

by Fabian Frank, Markus Hecht, Florian Loy, Sandra Rutzner, Rainer Fietkau, Luitpold Distel
Published 2021-12-01

Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhib...

by Jian-Guo Zhou, Benjamin Frey, Hu Ma, Markus Hecht, Sandra Rutzner, Ina Becker, Rainer Fietkau, Udo Gaipl, Anna-Jasmina Donaubauer, Philipp Schubert, Claudia Schweizer
Published 2021-02-01

Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors

by Philipp Schubert, Philipp Schubert, Sandra Rutzner, Sandra Rutzner, Markus Eckstein, Markus Eckstein, Benjamin Frey, Benjamin Frey, Claudia Schweizer, Claudia Schweizer, Marlen Haderlein, Marlen Haderlein, Sebastian Lettmaier, Sebastian Lettmaier, Sabine Semrau, Sabine Semrau, Antoniu-Oreste Gostian, Antoniu-Oreste Gostian, Jian-Guo Zhou, Jian-Guo Zhou, Jian-Guo Zhou, Udo S. Gaipl, Udo S. Gaipl, Rainer Fietkau, Rainer Fietkau, Markus Hecht, Markus Hecht
Published 2020-10-01

Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

by Luisa Maria Griewing, Claudia Schweizer, Philipp Schubert, Sandra Rutzner, Markus Eckstein, Benjamin Frey, Marlen Haderlein, Thomas Weissmann, Sabine Semrau, Antoniu-Oreste Gostian, Sarina K. Müller, Maximilian Traxdorf, Heinrich Iro, Jian-Guo Zhou, Udo S. Gaipl, Rainer Fietkau, Markus Hecht
Published 2021-03-01

Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy

by Carol I Geppert, Arndt Hartmann, Benjamin Frey, Markus Eckstein, Markus Hecht, Antoniu Oreste Gostian, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias G Hautmann, Gunther Klautke, Simon Laban, Thomas Brunner, Axel Hinke, Ina Becker, Sabine Semrau, Panagiotis Balermpas, Wilfried Budach, Heinrich Iro, Rainer Fietkau
Published 2020-07-01

Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8

by Carol I Geppert, Arndt Hartmann, Benjamin Frey, Markus Eckstein, Markus Hecht, Antoniu Oreste Gostian, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias G Hautmann, Gunther Klautke, Simon Laban, Thomas Brunner, Axel Hinke, Ina Becker, Sabine Semrau, Panagiotis Balermpas, Wilfried Budach, Heinrich Iro, Rainer Fietkau
Published 2020-07-01

Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer

by Sabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, Markus Eckstein, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias Hautmann, Gunther Klautke, Simon Laban, Thomas Brunner, Bálint Tamaskovics, Benjamin Frey, Jian-Guo Zhou, Carol-Immanuel Geppert, Arndt Hartmann, Panagiotis Balermpas, Wilfried Budach, Udo Gaipl, Heinrich Iro, Rainer Fietkau, Markus Hecht
Published 2021-04-01